July 12, 2017
Lilly reaches settlement agreement in U.S. Cialis patent litigation
Eli Lilly has entered into a settlement agreement with generic companies to resolve pending patent litigation in the U.S. District Court for the Eastern District of Virginia regarding the Cialis (tadalafil) unit dose patent.